Home
/
Aurinia Pharmaceuticals Inc.
/
Financials
/
Quarterly
Aurinia Pharmaceuticals Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Aurinia Pharmaceuticals Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$73.47M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$70.01M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$62.47M
May 12, 2025
Q3
2025
Sep 30, 2024
$67.77M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$57.19M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$50.30M
May 12, 2025
Q3
2024
Sep 30, 2023
$54.52M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$41.49M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$34.41M
May 2, 2024
Q3
2023
Sep 30, 2022
$55.78M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$28.19M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$21.63M
May 4, 2023
Q3
2022
Sep 30, 2021
$14.67M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$6.62M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$914.0K
May 10, 2022
Q3
2021
Sep 30, 2020
$29.0K
Nov 3, 2021
Q2
2021
Jun 30, 2020
$29.0K
Aug 5, 2021
Q1
2021
Mar 31, 2020
$30.0K
May 6, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$31.55M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$21.51M
Jul 31, 2025
Q3
2025
Jun 30, 2025
$21.51M
Nov 4, 2025
Q3
2025
Mar 31, 2025
$23.34M
Nov 4, 2025
Q1
2025
Mar 31, 2025
$23.34M
May 12, 2025
Q2
2025
Mar 31, 2025
$23.34M
Jul 31, 2025
Q3
2025
Sep 30, 2024
$14.35M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$722.0K
Jul 31, 2025
Q3
2025
Jun 30, 2024
$722.0K
Nov 4, 2025
Q2
2025
Mar 31, 2024
($10.75M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($10.75M)
May 12, 2025
Q3
2025
Mar 31, 2024
($10.75M)
Nov 4, 2025
Q3
2024
Sep 30, 2023
($13.45M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($11.49M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($26.21M)
May 2, 2024
Q3
2023
Sep 30, 2022
($8.99M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($35.52M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($37.63M)
May 4, 2023
Q3
2022
Sep 30, 2021
($50.26M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($47.01M)
Aug 4, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$29.75M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$20.08M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$21.85M
May 12, 2025
Q3
2025
Sep 30, 2024
$11.75M
Nov 4, 2025
Q2
2025
Jun 30, 2024
($1.51M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($13.25M)
May 12, 2025
Q3
2024
Sep 30, 2023
($16.26M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($16.17M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($29.58M)
May 2, 2024
Q3
2023
Sep 30, 2022
($9.50M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($35.99M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($37.88M)
May 4, 2023
Q3
2022
Sep 30, 2021
($50.35M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($47.13M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($50.54M)
May 10, 2022
Q3
2021
Sep 30, 2020
($42.32M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($26.86M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($27.06M)
May 6, 2021